Log In
BCIQ
Print this Print this
 

SoluMatrix naproxen (IP 890) (formerly Submicron naproxen)

  Manage Alerts
Collapse Summary General Information
Company Iroko Pharmaceuticals LLC
DescriptionLower dose formulation of the NSAID naproxen using SoluMatrix fine particle technology
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat moderate to severe pain; Treat osteoarthritis (OA) pain in adults
Regulatory Designation
PartneriCeutica Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today